Cite

    Korkosz, M. et al. (2014). Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity. Scandinavian journal of rheumatology. pp. 43-48. [Online].